Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

DNA Microarrays

DNA Microarrays

Microarrays are high-throughput and relatively inexpensive assays that can be automated to analyze large quantities of data at a time. They are used in genome-wide studies to compare gene or protein expression under two varied conditions, such as healthy and diseased states. Microarrays consist of glass or silica slides on which probe molecules are covalently attached through surface functionalization. Most commonly, the slides are prepared through the chemisorption of silanes to silica...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

EMQN: Recommendations for genetic testing in inherited cardiomyopathies and arrhythmias.

European journal of human genetics : EJHG·2023

Same author

Integrated multi-omics for rapid rare disease diagnosis on a national scale.

Nature medicine·2023

Same author

Author Correction: De novo assembly, characterization, functional annotation and expression patterns of the black tiger shrimp (Penaeus monodon) transcriptome.

Scientific reports·2022

Same author

Ethylmalonic encephalopathy masquerading as meningococcemia.

Cold Spring Harbor molecular case studies·2022

Same author

Genome assembly of the Australian black tiger shrimp (Penaeus monodon) reveals a novel fragmented IHHNV EVE sequence.

G3 (Bethesda, Md.)·2022

Same author

Standardized practices for RNA diagnostics using clinically accessible specimens reclassifies 75% of putative splicing variants.

Genetics in medicine : official journal of the American College of Medical Genetics·2021

Search research articles

Related Experiment Video

Updated: Jul 20, 2026

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

Detection of mutations in genes associated with hearing loss using a microarray-based approach.

Kirby Siemering¹, Shehnaaz S M Manji, Wendy M Hutchison

¹Murdoch Childrens Research Institute, Royal Children's Hospital, Parkville, Victoria 3052, Australia.

The Journal of Molecular Diagnostics : JMD

|August 26, 2006

Summary

A new hearing loss biochip accurately detects common genetic mutations causing nonsyndromic sensorineural hearing loss. This cost-effective tool aids in diagnosing the genetic etiology of hearing impairment for better patient management.

More Related Videos

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Neonatal Murine Cochlear Explant Technique as an In Vitro Screening Tool in Hearing Research

Neonatal Murine Cochlear Explant Technique as an In Vitro Screening Tool in Hearing Research

Published on: June 8, 2017

Related Experiment Videos

Last Updated: Jul 20, 2026

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Neuro-rehabilitation Approach for Sudden Sensorineural Hearing Loss

Published on: January 25, 2016

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Demonstrating a Multi-drug Resistant Mycobacterium tuberculosis Amplification Microarray

Published on: April 25, 2014

Neonatal Murine Cochlear Explant Technique as an In Vitro Screening Tool in Hearing Research

Neonatal Murine Cochlear Explant Technique as an In Vitro Screening Tool in Hearing Research

Published on: June 8, 2017

Area of Science:

Genetics
Audiology
Molecular Biology

Background:

Over 50% of early-onset, nonsyndromic sensorineural hearing loss (NSHL) is genetically determined.
The genetic heterogeneity of deafness makes comprehensive mutation screening economically and practically challenging.
Identifying the etiology of hearing loss is crucial for effective counseling and management.

Purpose of the Study:

To develop and validate a microarray-based hybridization biochip assay for detecting known mutations associated with hearing loss.
To provide a cost-effective and efficient method for identifying the genetic causes of NSHL.

Main Methods:

Development of a microarray-based hybridization biochip assay.
The current biochip version targets nine common mutations in the connexin 26 gene, four in the pendrin gene, one in the usherin gene, and one in mitochondrial DNA.
Validation was performed using DNA from 250 individuals with apparent NSHL.

Main Results:

The hearing loss biochip demonstrated 100% accuracy in detecting the targeted mutations.
No false-positive or false-negative results were observed during validation.
The assay is scalable for inclusion of additional deafness-related gene mutations.

Conclusions:

The developed hearing loss biochip is a highly accurate and reliable tool for detecting specific genetic mutations linked to hearing impairment.
This assay offers a practical and potentially cost-effective solution for genetic diagnosis of hearing loss.
The platform's expandability allows for future integration of more genetic markers for comprehensive genetic screening.